Microfluidic Biological Sample Analysis with Gallery Data Organization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Biological assays on microfluidic devices generate extremely large datasets with unstructured data elements, making it difficult for researchers to visualize and analyze processes, especially over time, and derive meaningful information from multiple micro-objects simultaneously, which hinders efficient therapeutic antibody discovery and rapid drug screening.

Innovation Solution

A method and system for analyzing biological samples by identifying regions of interest in a microfluidic device, correlating temporal data with a workflow, and rendering associated data in a user interface, using gallery structures and interactive objects to visualize and manipulate data effectively.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If biological assays are performed on microfluidic devices to achieve high throughput, then the quantity of biological samples that can be analyzed is improved, but the size of datasets becomes extremely large and unstructured, making visualization and analysis difficult

Engineering Contradiction:
Improvethroughput of biological assaysVSAvoidcomplexity of data structure and visualization
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent segments the complex dataset into structured components by organizing data into galleries with specific categories (e.g., by region of interest, by time point, by sample type). Each gallery acts as an independent organizational unit that can be separately managed and visualized, transforming the unstructured data mass into manageable segments while preserving the high throughput capability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces temporal dimensionality by organizing data across multiple time points in a structured timeline framework. This adds a new dimension to data organization beyond simple spatial arrangement, enabling researchers to visualize and analyze changes over time while maintaining the ability to handle large volumes of data through structured categorization.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Quantity of substance

If large datasets from multiple biological samples are generated, then the quantity of information is improved, but the time required to visualize and analyze the data increases

Engineering Contradiction:
Improvequantity of biological sample dataVSAvoidtime for data visualization and analysis
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The patent performs preliminary organization of data into structured galleries and timelines during or immediately after data collection. By pre-organizing data into categorical structures before analysis begins, the system eliminates the need for time-consuming post-collection sorting and organizing, allowing researchers to directly analyze structured data while maintaining access to large quantities of information.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent creates virtual copies of data organized in multiple galleries and views that can be independently accessed and manipulated. Instead of working with the entire massive dataset at once, researchers can create and switch between specialized views (e.g., by sample type, by time point, by region), effectively copying the data into manageable representations that reduce analysis time while preserving access to the full quantity of information.

Inventive Principle:
Principle #26Copying

3Loss of information

If unstructured data elements are collected from biological assays, then the completeness of data is improved, but the ease of manipulating and synthesizing information deteriorates

Engineering Contradiction:
Improvecompleteness of data collectionVSAvoidease of data manipulation and synthesis
Core Design Contradiction:
Loss of informationVSEase of operation

Solution Approach 1:

The patent segments unstructured data into structured categories within galleries, organizing data elements by type, source, and temporal relationship. This segmentation process maintains the completeness of the original data while transforming it into manipulable structures that can be easily queried, filtered, and synthesized through the organized framework.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces structured data organizations (galleries, timelines, views) as intermediary layers between the raw unstructured data and the researcher's analysis operations. These intermediaries serve as mediators that preserve the completeness of the original data while providing structured access points and manipulation interfaces, making the data both complete and easy to work with.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Measurement precision

If researchers manually analyze individual micro-objects, then the precision of analysis is improved, but the productivity and throughput are reduced

Engineering Contradiction:
Improveprecision of micro-object analysisVSAvoidthroughput of analysis
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent creates a universal data organization framework that can handle multiple types of micro-objects and analysis operations within a single system. The gallery and timeline structures serve as multi-functional containers that can organize different sample types, time points, and analysis parameters simultaneously, enabling precise analysis of individual micro-objects while maintaining high throughput through automated data management and structured access.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20230105220A1Systems and methods for analyses of biological samples
Publication Date: 2023.04.06 BRUKER CELLULAR ANALYSIS INC
  • US20230105220A1 patent drawing
  • US20230105220A1 patent drawing
  • US20230105220A1 patent drawing

AI summary

Disclosed are methods, systems, and articles of manufacture for performing a process on biological samples. An analysis of biological samples in multiple regions of interest in a microfluidic device and a timeline correlated with the analysis may be identified. One or more region-of-interest types for the multiple regions of interest may be determined; and multiple characteristics may be determined for the biological samples based at least in part upon the one or more region-of-interest types. Associated data that respectively correspond to the multiple regions of interest in a user interface for at least a portion of the biological samples in the user interface based at least in part upon the multiple identifiers and the timeline. A count of the biological samples in a region of interest may be determined based at least in part upon a class or type of data using a convolutional neural network (CNN).